Abstract
Rheumatoid arthritis has a significant economic burden due to its direct and indirect costs. Our aim was to determine the annual health insurance treatment cost of seropositive rheumatoid arthritis in Hungary.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have